Medications starting with
Ukraine-
Obajio is indicated for the treatment of adult patients and children aged 10 years and older with relapsing multiple sclerosis.
Dosage form: tablets, film-coated
Active substance Dosage teriflunomide 7 mg ATC code: L04AK02
Manufacturer: Opella Healthcare International SAS
-
The drug is indicated for the treatment of adult patients and children aged 10 years and older with relapsing-remitting multiple sclerosis.
Dosage form: tablets, film-coated
Active substance Dosage teriflunomide 14 mg ATC code: L04AK02
Manufacturer: Opella Healthcare International SAS
-
The drug is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (including clinically isolated syndrome, relapsing-remitting, and active secondary progressive disease), as well as primary progressive multiple sclerosis.
Dosage form: concentrate for infusion solution
Active substance Dosage ocrelizumab 30 mg/ml ATC code: L04AG08
-
The drug is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS) with signs of active disease, as well as for the treatment of adults with early primary progressive multiple sclerosis (PPMS).
Dosage form: solution for injection
Active substance Dosage ocrelizumab 920 mg/23 ml ATC code: L04AG08
-
The drug is used for replacement therapy in primary immunodeficiency syndromes and secondary immunodeficiencies. It is also used for immunomodulation in idiopathic thrombocytopenic purpura, Guillain-Barré syndrome, Kawasaki disease, chronic inflammatory demyelinating polyneuropathy, and multifocal motor neuropathy.
Dosage form: solution for infusion
Active substance Dosage total protein human immunoglobulin 50 mg/ml ATC code: J06BA02
Manufacturer: Octapharma Pharmaceuticals Productionsges. m.b.H.
-
The drug is used for the treatment and prevention of bleeding in patients with hemophilia A (congenital factor VIII deficiency).
Dosage form: powder for injection solution
Active substance Dosage human blood coagulation factor viii 1000 IU ATC code: B02BD02
Manufacturer: Octapharma AB (manufacturing through the full cycle except secondary packaging)
-
The drug is used for the treatment and prevention of bleeding in patients with hemophilia A (congenital factor VIII deficiency).
Dosage form: powder for injection solution
Active substance Dosage human blood coagulation factor viii 250 IU or 500 IU ATC code: B02BD02
Manufacturer: Octapharma AB (manufacturing through the full cycle except secondary packaging)
-
The drug is used for the treatment and prevention of bleeding in patients with hemophilia B (congenital factor IX deficiency).
Dosage form: powder for injection solution
Active substance Dosage human factor ix 100 IU/ml ATC code: B02BD04
-
The drug is used for the treatment and prevention of bleeding in patients with hemophilia B (congenital factor IX deficiency).
Dosage form: powder for injection solution
Active substance Dosage human coagulation factor ix 100 IU/ml ATC code: B02BD04
-
Octaplas lg is indicated for complex coagulation factor deficiency causing coagulation disorders due to liver insufficiency or massive hemorrhage. It is also used for coagulation factor replacement in the deficiency of specific factors when they are unavailable, or for therapy in coagulation disorders caused by factor S deficiency.
Dosage form: solution for infusion
Active substance Dosage human blood plasma proteins 45 - 70 mg/ml ATC code: B05AA
Manufacturer: Octapharma AB (manufacturer responsible for full-cycle production)
-
The drug is used for the treatment of bleeding and the prevention of bleeding during surgery in cases of acquired coagulation factor deficiency (e.g., due to vitamin K antagonists) or in cases of congenital deficiency of factors II and X.
Dosage form: powder and solvent for infusion solution
Active substance Dosage human coagulation factor complex (factor ii, factor vii, factor ix, factor x, protein c, protein s) 500 IU ATC code: B02BD01
Manufacturer: Octapharma Pharmazeutika Productionsges m.b.H. (manufacturer responsible for full-cycle production)
-
The preparation is used as an antiseptic for treating skin, wounds, burns, and mucous membranes. It is used to prepare the anogenital area before medical procedures, to treat bacterial and fungal vaginal infections, as well as for oral cavity treatment and the treatment of interdigital mycosis.
Dosage form: solution
Active substance Dosage octenidine dihydrochloride 0.10 g/100 g 2-phenoxyethanol 2.00 g/100 g ATC code: D08AJ57
Manufacturer: Schuelke & Mayr GmbH
-
The drug is used to normalize or shorten bleeding time before medical interventions, as well as to treat bleeding in cases of uremia, liver cirrhosis, platelet dysfunction, or unknown causes of bleeding. It is also used for the prevention and treatment of bleeding in mild forms of hemophilia type A and von Willebrand disease.
Dosage form: solution for injection
Active substance Dosage desmopressin 15 mcg/ml ATC code: H01BA02
Manufacturer: Ferring GmbH (manufacturing, primary packaging, responsible for quality control, batch release)
-
The drug is used to control the symptoms of acromegaly (lowering growth hormone levels), to alleviate conditions in endocrine tumors of the gastrointestinal tract and pancreas, to prevent complications after pancreatic surgery, and to stop and prevent recurrent bleeding from esophageal and gastric veins in liver cirrhosis.
Dosage form: solution for injection
Active substance Dosage octreotide 0.1 mg/ml ATC code: H01CB02
Manufacturer: Farmak JSC
-
The drug is used to control the manifestations of acromegaly (lowering growth hormone levels), alleviate the symptoms of endocrine tumors of the gastrointestinal tract and pancreas, prevent complications after pancreatic surgery, and to stop bleeding from esophageal and gastric varices in patients with liver cirrhosis.
Dosage form: solution for injection and infusion
Active substance Dosage octreotide 0.1 mg/ml ATC code: H01CB02
-
The drug is used to control the manifestations of acromegaly (reduction of growth hormone levels), alleviate the symptoms of endocrine tumors of the gastrointestinal tract and pancreas, as well as for the prevention of complications after pancreatic surgery and the management of bleeding in esophageal varices.
Dosage form: solution for injection
Active substance Dosage octreotide 0.05 mg/ml ATC code: H01CB02
Manufacturer: Bendalis GmbH (manufacturer responsible for batch release)
-
The drug is used to control the symptoms of acromegaly (lowering growth hormone levels), to alleviate the condition in endocrine tumors of the gastrointestinal tract and pancreas, and to stop bleeding from the veins of the esophagus and stomach in cases of liver cirrhosis.
Dosage form: solution for injection
Active substance Dosage octreotide 0.1 mg/ml ATC code: H01CB02
Manufacturer: Bendalis GmbH (manufacturer responsible for batch release)
-
The drug is used to control the manifestations of acromegaly (lowering growth hormone levels), alleviate symptoms of endocrine tumors of the gastrointestinal tract and pancreas, prevent complications after pancreatic surgery, and to stop bleeding from the veins of the esophagus and stomach in cases of liver cirrhosis.
Dosage form: solution for injection
Active substance Dosage octreotide 0.5 mg/ml ATC code: H01CB02
Manufacturer: Bendalis GmbH (manufacturer responsible for batch release)
-
The drug is used as an antiseptic for treating skin, wounds, burns, and mucous membranes. It is applied to prepare the skin before medical procedures, to treat bacterial and fungal infections (including in the vaginal area), and for maintenance therapy for interdigital fungal infections.
Dosage form: solution
Active substance Dosage octenidine dihydrochloride 1 mg/ml phenoxyethanol 20 mg/ml ATC code: D08AJ57
Manufacturer: Farmak JSC
-
The drug is used to treat functional lower urinary tract disorders associated with benign prostatic hyperplasia.
Dosage form: capsules, extended-release
Active substance Dosage tamsulosin 0.4 mg ATC code: G04CA02
Manufacturer: Aurobindo Pharma Limited - Unit VII
-
The drug is indicated for the treatment of adults with idiopathic pulmonary fibrosis (IPF), other chronic fibrosing interstitial lung diseases (ILD) with a progressive phenotype, and interstitial lung disease associated with systemic sclerosis.
Dosage form: capsules, soft gelatin
Active substance Dosage nintedanib 100 mg ATC code: L01EX09
-
The drug is indicated for the treatment of adults with idiopathic pulmonary fibrosis (IPF), other chronic fibrosing interstitial lung diseases with a progressive phenotype, and interstitial lung disease associated with systemic sclerosis.
Dosage form: capsules, soft gelatin
Active substance Dosage nintedanib 150 mg ATC code: L01EX09
-
The ointment is used for the treatment and prevention of infected wounds, burns, pressure sores, trophic ulcers, abscesses, and other purulent skin diseases caused by bacteria sensitive to antibiotics.
Dosage form: ointment
Active substance Dosage ofloxacin 1 mg/g lidocaine 30 mg/g ATC code: D06BX
Manufacturer: PJSC «Pharmaceutical Company «Darnitsa»
-
The drug is used to treat infectious and inflammatory diseases caused by bacteria sensitive to it. In particular, it is used for exacerbations of chronic obstructive pulmonary disease, pneumonia, urinary tract infections (cystitis, urethritis, pyelonephritis), and complicated skin and soft tissue infections.
Dosage form: solution for infusion
Active substance Dosage ofloxacin 200 mg/100 ml ATC code: J01MA01
Manufacturer: Evrolife Healthcare Pvt. Ltd.
-
The drug is prescribed to adults for the treatment of bacterial infections, such as acute pyelonephritis, complicated urinary tract infections, bacterial prostatitis, epididymo-orchitis, salmonellosis, urosepsis, and inflammatory diseases of the pelvic organs. It may also be used for bone and joint infections, complicated skin infections, acute bacterial sinusitis, exacerbation of COPD, and non-hospital pneumonia.
Dosage form: solution for infusion
Active substance Dosage ofloxacin 0.2 percent ATC code: J01MA01
Manufacturer: PJSC "Infuziya"
-
The drug is used to treat infectious and inflammatory diseases caused by bacteria sensitive to it. In particular, it is prescribed for exacerbations of chronic obstructive pulmonary disease, pneumonia, urinary tract infections (cystitis, urethritis, pyelonephritis), and complicated skin and soft tissue infections.
Dosage form: solution for infusion
Active substance Dosage ofloxacin 2 mg/ml ATC code: J01MA01
Manufacturer: Yuria-Pharm LLC
-
The drug is used to treat infectious and inflammatory diseases caused by bacteria sensitive to it. In particular, it is prescribed for acute exacerbations of chronic bronchitis, community-acquired pneumonia, acute pyelonephritis, complicated urinary tract infections, urethritis, cervicitis, and complicated skin and soft tissue infections.
Dosage form: tablets
Active substance Dosage ofloxacin 0.2 g ATC code: J01MA01
Manufacturer: PJSC "Lekhim - Kharkiv"
-
The drug is used to treat infectious and inflammatory diseases caused by bacteria sensitive to it. Specifically, these include exacerbations of chronic bronchitis and chronic obstructive pulmonary disease, community-acquired pneumonia, acute pyelonephritis, complicated urinary tract infections, urethritis, cervicitis, as well as complicated skin and soft tissue infections.
Dosage form: tablets, film-coated
Active substance Dosage ofloxacin 200 mg ATC code: J01MA01
Manufacturer: FDS Limited
-
The drug is used for infectious and inflammatory diseases caused by bacteria sensitive to it. Specifically, these include exacerbations of chronic bronchitis and chronic obstructive pulmonary disease, community-acquired pneumonia, acute pyelonephritis, complicated urinary tract infections, urethritis, cervicitis, as well as complicated skin and soft tissue infections.
Dosage form: tablets, film-coated
Active substance Dosage ofloxacin 400 mg ATC code: J01MA01
Manufacturer: FDS Limited
-
The drug is used to treat infections of the anterior segment of the eye caused by bacteria sensitive to it. These may include inflammation of the conjunctiva, cornea, eyelid margins, or lacrimal sac, as well as stye and corneal ulcer.
Dosage form: drops, ophthalmic
Active substance Dosage ofloxacin 3 mg/ml ATC code: S01AE01
Manufacturer: Pharma Stuln GmbH
-
The drug is used to treat infectious and inflammatory diseases caused by bacteria sensitive to it. In particular, it is prescribed for exacerbations of chronic bronchitis and pneumonia, urinary tract infections (cystitis, pyelonephritis, urethritis), complicated skin infections, as well as gonococcal urethritis and cervicitis.
Dosage form: tablets
Active substance Dosage ofloxacin 200 mg ATC code: J01MA01
Manufacturer: PJSC «Pharmaceutical Company «Darnitsa»
-
The drug is used for the topical treatment of external eye infections (e.g., conjunctivitis and keratitis) in adults and children, if they are caused by microorganisms sensitive to this agent.
Dosage form: drops, ophthalmic
Active substance Dosage ofloxacin 3 mg/ml ATC code: S01AE01
Manufacturer: Farmex Group LLC
-
The drug is intended to arrest the development of cataracts. It can also be used for prevention, as well as for non-infectious inflammatory processes of the anterior segment of the eye.
Dosage form: drops, ophthalmic solution
Active substance Dosage cytochrome c 0.675 mg/ml adenosine 2 mg/ml nicotinamide 20 mg/ml ATC code: S01XA
Manufacturer: LLC "FARMEKS GROUP"
-
The drug is used to treat allergic and vernal conjunctivitis, blepharitis, blepharo-conjunctivitis, allergic keratoconjunctivitis, as well as scleritis, episcleritis, and uveitis.
Dosage form: drops, ophthalmic solution
Active substance Dosage dexamethasone 0.342 mg ATC code: S01BA01
Manufacturer: Farmigea S.p.A.
-
The drug is used for the symptomatic treatment of dry eye syndrome and dry keratoconjunctivitis.
Dosage form: gel, ophthalmic
Active substance Dosage carbomer 974p 2.5 mg/g ATC code: S01XA20
-
The drug is used for the complex treatment of infections of the anterior segment of the eye (e.g., conjunctivitis, keratitis, blepharitis), as well as for eye injuries and burns. It is also used for the prevention of infections before surgery and to protect newborns from ophthalmia.
Dosage form: drops, ophthalmic solution
Active substance Dosage miramistin 0.1 mg/ml ATC code: S03D
Manufacturer: PJSC «Pharmaceutical Company «Darnitsa»
-
The drug is used for the temporary relief of eye redness caused by mild irritation or allergic conjunctivitis.
Dosage form: drops, ophthalmic solution
Active substance Dosage tetryzoline 0.5 mg/ml ATC code: S01GA02
Manufacturer: LLC "Research Plant "GNCLS" (all manufacturing stages, quality control, batch release)
-
The drug is prescribed for ocular hemorrhages, angioretinopathies (including diabetic retinopathy), retinal vascular thrombosis, corneal dystrophic diseases, corneal injuries, and burns. It is also used to protect the retina and cornea from the effects of bright light or laser.
Dosage form: solution for injection
Active substance Dosage methylethylpyridinol 10 mg/ml ATC code: C05CX
Manufacturer: PJSC "Lekhim - Kharkiv"
-
The drug is used to treat acute and chronic conjunctivitis, blepharo-conjunctivitis, gonococcal conjunctivitis, and chlamydial infection of the ocular mucosa. It is also used for the prevention of ophthalmia neonatorum in newborns, before and after ophthalmic surgeries, as well as for the treatment of contact lenses.
Dosage form: drops, ophthalmic
Active substance Dosage decamethoxin 0.2 mg/ml ATC code: S01AX
Manufacturer: LLC "Research Plant "GNCLS" (all manufacturing stages, quality control, batch release)
-
The drug is used to treat eye infections (blepharitis, conjunctivitis, keratitis), eye injuries and burns, as well as to treat otitis (ear inflammation) and rhinitis (inflammation of the nasal mucosa). It is also used for the prevention of infections in newborns and before surgeries.
Dosage form: drops, ophthalmic/otic/nasal, solution
Active substance Dosage miramistin 0.1 mg/ml Manufacturer: PJSC «Pharmaceutical Company «Darnitsa»
-
The drug is intended to delay the development of cataracts. It can also be used for prophylactic purposes.
Dosage form: drops, ophthalmic
Active substance Dosage cytochrome c 0.675 mg/ml adenosine 2 mg/ml nicotinamide 20 mg/ml ATC code: S01XA
Manufacturer: Santen AG (manufacturer responsible for batch release)
-
The drug is used to treat non-purulent inflammatory and allergic eye diseases, such as conjunctivitis, keratitis, iritis, iridocyclitis, as well as corneal injuries, marginal ulcers, and postoperative conditions.
Dosage form: drops, ophthalmic
Active substance Dosage dexamethasone 1 mg/ml ATC code: S01BA01
Manufacturer: Santen AG (manufacturer, responsible for batch release)
-
The drug is used to treat open-angle glaucoma, increased intraocular pressure, post-cataract surgery glaucoma, as well as in some cases of secondary glaucoma. It is also used for the treatment of angle-closure glaucoma in combination with miotics.
Dosage form: drops, ophthalmic
Active substance Dosage timolol 5 mg/ml ATC code: S01ED01
Manufacturer: Santen AG (manufacturer, responsible for batch release)
-
The drug is used for the local treatment of bacterial eye infections in patients aged 1 year and older, caused by microorganisms sensitive to levofloxacin.
Dosage form: drops, ophthalmic
Active substance Dosage levofloxacin 5 mg/ml ATC code: S01AE05
Manufacturer: Santen AG (manufacturer, responsible for batch release)
-
The drug is used for the topical treatment of external bacterial eye infections in patients aged 1 year and older, caused by microorganisms sensitive to it.
Dosage form: drops, ophthalmic
Active substance Dosage levofloxacin 5 mg/ml ATC code: S01AE05
Manufacturer: Santen AG (manufacturer responsible for batch release)
-
The drug is used for the treatment of ocular hypertension, chronic open-angle glaucoma, and certain cases of secondary glaucoma.
Dosage form: drops, ophthalmic
Active substance Dosage timolol 2.5 mg/ml ATC code: S01ED01
Manufacturer: Farmak JSC
-
The drug is used to reduce elevated intraocular pressure in ocular hypertension, chronic open-angle glaucoma, and certain cases of secondary glaucoma.
Dosage form: drops, ophthalmic
Active substance Dosage timolol 5 mg/ml ATC code: S01ED01
Manufacturer: Farmak JSC
-
The drug is used for 'dry eye' syndrome (when irritation, redness, and discomfort are felt due to a lack of tear fluid) and for dry keratoconjunctivitis.
Dosage form: drops, ophthalmic
Active substance Dosage polyvinyl alcohol 14 mg/ml povidone 6 mg/ml ATC code: S01XA20
Manufacturer: Centiss Pharma Pvt. Ltd.
-
The drug is prescribed to adults for the treatment of neuropathic pain (resulting from peripheral and central nervous system damage), as adjunctive therapy in epilepsy (partial seizures), and for the treatment of generalized anxiety disorder and fibromyalgia.
Dosage form: capsules
Active substance Dosage pregabalin 75 mg ATC code: N03AX16
Manufacturer: Farmak JSC
-
The drug is prescribed for adults to treat neuropathic pain (in cases of peripheral and central nervous system damage), as adjunctive therapy for epilepsy (partial seizures), and for the treatment of generalized anxiety disorder and fibromyalgia.
Dosage form: capsules
Active substance Dosage pregabalin 300 mg ATC code: N03AX16
Manufacturer: Farmak JSC